NEW YORK (Reuters Health) – New research suggests that extracorporeal shock-wave therapy (ESWT) is a viable alternative to surgery for long-bone hypertrophic nonunions. “When we examined patients and…
NEW YORK (Reuters Health) – Exercise-induced ST-segment elevation in patients who never had a myocardial infarction (MI) is a highly specific marker of coronary artery disease and a…
NEW YORK (Reuters Health) – No matter whether they receive biological or mechanical prosthetic aortic valves, patients have generally similar survival and complication rates — until 10 years…
NEW YORK (Reuters Health) – Interest in off-pump coronary artery bypass grafting (CABG) grew in the mid-1990s based on the belief that it could reduce the complications seen…
NEW YORK (Reuters Health) – Intravenous infusions of iron sucrose before planned colorectal cancer surgery does not reduce perioperative blood transfusions, according to a report in the British…
NEW YORK (Reuters Health) – Men with localized prostate cancer treated with external beam radiotherapy (EBRT) are apt to have better sexual function afterward than men treated with…
NEW YORK (Reuters Health) – Women who regularly use nonsteroidal anti-inflammatory drugs (NSAIDs) have better survival after a colorectal cancer (CRC) diagnosis, research indicates. “A wide body of…
NEW YORK (Reuters Health) – Although diclofenac is commonly used to treat acute pain in children, it is not licensed for this purpose in all age groups. A…
NEW YORK (Reuters Health) – Neoadjuvant treatment with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor, can help downstage bladder cancer to organ-confined disease, thereby increasing the…
NEW YORK (Reuters Health) – Coronary angiography is a recommended screening test for many patients undergoing kidney transplantation and now new research shows that it can be performed…